Ron Squarer's Net Worth
$26.7 Million
Who is Ron Squarer?
Ron Squarer has an estimated net worth of $26.7 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., Deciphera Pharmaceuticals, Inc., ARRAY BIOPHARMA INC, HOSPIRA INC, and ADC Therapeutics SA.
SEC CIK
Ron Squarer's CIK is 0001454001
Past Insider Trading and Trends
2017 was Ron Squarer's most active year for acquiring shares with 12 total transactions. Ron Squarer's most active month to acquire stocks was the month of November. 2019 was Ron Squarer's most active year for disposing of shares, totalling 18 transactions. Ron Squarer's most active month to dispose stocks was the month of June. 2017 saw Ron Squarer paying a total of $4,985,625.44 for 1,664,960 shares, this is the most they've acquired in one year. In 2019 Ron Squarer cashed out on 4,562,346 shares for a total of $19,190,816.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.05% | 6.5K |
—
|
—
| 28.88K |
May 8
| |||
Form 4
| +25.17% | 4.5K |
—
|
—
| 22.38K |
May 17
| |||
Form 4
| +20.17% | 3K |
—
|
—
| 17.88K |
May 11
| |||
Form 4
| +25.26% | 3K |
—
|
—
| 14.88K |
May 14
| |||
Form 4
| +33.80% | 3K |
—
|
—
| 11.88K |
May 15
| |||
Form 4
| +29.09% | 2K |
—
|
—
| 8.88K |
May 8
| |||
Form 4
| +57.14% | 2.5K |
—
|
—
| 6.88K |
May 9
| |||
Form 4
|
∞
| 4.38K |
—
|
—
| 4.38K |
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Deciphera Pharmaceuticals, Inc. (DCPH) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARRAY BIOPHARMA INC No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -702.08K |
$48.00 |
—
|
0
|
Jul 30
| |||
Form 4
| +8.87% | 21.18K |
$24.60 | -$409,122.60 | 259.89K |
Apr 1
| |||
Form 4
|
—
|
0
|
$12.63 | -$1,982,915.00 | 238.71K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
$11.99 | -$2,737,813.64 | 238.71K |
Scheduled
|
Jan 30 - Jan 31
| ||
Form 4
| +12.82% | 27.13K |
$15.97 | -$340,208.91 | 238.71K |
Dec 14 - Dec 16
| |||
Form 4
|
—
|
0
|
$13.42 | -$2,707,016.22 | 211.57K |
Scheduled
|
Jun 27
| ||
Form 4
| +1.10% | 2.3K |
$16.32 | -$270,993.60 | 211.57K |
Apr 1
| |||
Form 4
| +80.90% | 93.59K |
$8.20 | -$4,037,904.63 | 209.27K |
Scheduled
|
Dec 16 - Dec 19
| ||
Form 4/A
| -13.18% | -17.56K |
$8.94 | -$157,013.22 | 115.68K |
Apr 1
| |||
Form 4
| +6.39% | 6.86K |
$8.94 | -$107,655.48 | 114.33K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| -5.19% | -5.88K |
$3.00 | -$17,634.00 | 107.46K |
Apr 1
| |||
Form 4
| +232.40% | 75.63K |
—
|
—
| 108.17K |
Apr 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 12.93K |
$8.05 | $91,298.92 | 12.93K |
Mar 1 - Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
∞
| 4.4K |
—
|
—
| 4.4K |
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOSPIRA INC No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.59K |
$52.46 | -$126,218.76 | 5.59K |
Feb 24
| |||
Form 4
| +80.99% | 8K |
$43.70 | -$642,105.76 | 17.88K |
Scheduled
|
Jun 23 - Jul 6
| ||
Form 4
| -31.22% | -3.12K |
$56.86 | -$177,516.92 | 6.88K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
∞
| 3K |
$24.80 | $74,400.00 | 3K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADC Therapeutics SA (ADCT) Snapshot price: $2.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.98% | -7.00K |
$2.89 | -$20,215.55 | 80.66K |
Jun 17
| |||
Form 4
| +83.93% | 40K |
—
|
—
| 87.66K |
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||